InvestorsHub Logo
Followers 241
Posts 12342
Boards Moderated 0
Alias Born 08/14/2003

Re: hopester post# 35104

Sunday, 05/17/2020 2:11:48 PM

Sunday, May 17, 2020 2:11:48 PM

Post# of 44784
If you're looking to buy more that level may be important, if not should it be of concern. I don't think so. I believe the next thing we may be concerned about is when the added people on compassionate use reach the 28 day mark, when the company is saying they'll be reported on. If most of these people are of ventilator, and if few or none have died, what do you believe happens to the share price. I believe that $20 could be in play.

I also wouldn't be surprised if some countries acted on that information and didn't wait for the Phase 2 Trial to make it available to their people. Time will tell, but anecdotal evidence when it's really strong can cause such things, perhaps even Trump gets excited, Fauci and others may want to wait, but if out of over 20 people on ventilators only one or two passed on and all, or nearly all others were off the ventilators, and many discharged from the hospital, I believe you have the sort of story that some will act on, not waiting for further validation. I should add, their action might be conditional, requiring confirmation from the trial, but it would provide the drug to all until there was a reason not to.

Gary